<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36687403</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Chinese medicine for residual symptoms of COVID-19 recovered patients (long COVID)-A double-blind, randomized, and placebo-controlled clinical trial protocol.</ArticleTitle><Pagination><StartPage>990639</StartPage><MedlinePgn>990639</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">990639</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.990639</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Coronavirus disease 2019 (COVID-19) is the current global pandemic of which residual symptoms exhibited by post-acute, rehabilitating patients include fatigue, dyspnoea, and insomnia. Chinese medicine (CM) has been widely used in China to treat different stages of COVID-19. While there are a significant number of clinical studies suggesting its efficacy and safety in its use during acute stage, there are very few randomized controlled trials focusing on the rehabilitation stage. Liujunzhi Decoction and Shashen Maidong Decoction are frequently recommended by official clinical guidelines in China to treat COVID-19 patients in rehabilitation stage. This double-blind, randomized, placebo controlled study aims to evaluate the efficacy and safety of the combination of the two formulae [named "COVID-19 Rehab Formula (CRF)"] in treating COVID-19 residual symptoms (long COVID).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Eligible subjects will be randomly divided into treatment group and control group in 1:1 ratio. Treatment group will receive CRF along with certain pre-defined CM according to symptoms for 8 weeks, while control group will receive equivalent packs of placebo for 8 weeks. Data in terms of Fatigue Severity Score (FSS), self-reported COVID-19 long term symptom assessment, the modified British Medical Research Council (mMRC) Dyspnoea Scale, EuroQol Five-Dimension Five-Level (EQ-5D-5L) Questionnaire, pulmonary function test and adverse events will be collected and analyzed by SPSS 24. Blood test on liver and renal functions will also be conducted as safety measures.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This study will evaluate the efficacy and safety of CRF in the treatment COVID-19 residual symptoms in a scientifically rigorous design.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="UNASSIGNED">[ClinicalTrials.gov], identifier [NCT04924881].</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Sum, Ching, Song, Cheong, Lo, Lai, Chia, Chan, Mak, Leung, Leung, Zhang and Lin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sum</LastName><ForeName>Chi Him</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ching</LastName><ForeName>Jessica Yuet Ling</ForeName><Initials>JYL</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Tianhe</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheong</LastName><ForeName>Pui Kuan</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Cho Wing</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Mei Kwan</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chia</LastName><ForeName>Chon Pin</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Kam Leung</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mak</LastName><ForeName>Wing Yan</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Ka Chun</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Sin Bond</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hongwei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhixiu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04924881</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chinese medicine</Keyword><Keyword MajorTopicYN="N">alternative and complementary medicine</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">protocol</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The study will be conducted in compliance with the Declaration of Helsinki and ICH-GCP guidelines.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>23</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36687403</ArticleId><ArticleId IdType="pmc">PMC9846609</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.990639</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization Regional Office for Europe. Coronavirus Disease (Covid-19) Pandemic. Copenhagen: World Health Organization Regional Office for Europe; (2022).</Citation></Reference><Reference><Citation>World Health Organization. Weekly Epidemiological Update on Covid-19. Geneva: World Health Organization; (2022).</Citation></Reference><Reference><Citation>Cascella M, Rajnik M, Aleem A, Dulebohn S, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (Covid-19). Statpearls. Treasure Island, FL: StatPearls Publishing LLC; (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of Covid-19 infection: a cross-sectional evaluation. J Med Virol. (2021) 93:1013&#x2013;22. 10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute Covid-19. JAMA. (2020) 324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-Month consequences of Covid-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. 10.1016/s0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing G, Zhang H, Bai Y, Luo Y. Traditional Chinese and Western Medicines jointly beat Covid-19 pandemic. Chin J Integr Med. (2020) 26:403&#x2013;4. 10.1007/s11655-020-3095-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-020-3095-6</ArticleId><ArticleId IdType="pmc">PMC7195906</ArticleId><ArticleId IdType="pubmed">32361935</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission of the People&#x2019;s Republic of China. Transcript of Press Conference on on February 4, 2020. Beijing: National Health Commission of the People&#x2019;s Republic of China; (2020).</Citation></Reference><Reference><Citation>Cheng D, Li Y. Clinical effectiveness and case analysis in 54 NCP Patients Treated with Lanhuaqingwen Granules. World Chin Med. (2020) 15:150&#x2013;4.</Citation></Reference><Reference><Citation>Duan C, Xia W, Zheng C, Sun G, Li Z, Li Q, et al. Clinical observation on Jinhua Qinggan Granule (&#x91d1;&#x82b1;&#x6e05;&#x611f;&#x9897;&#x7c92;) combined with conventional western medicine therapy in treating mild cases of Coronavirus Disease 2019. J. Trad. Chin. Med. (2020) 61:1473&#x2013;7.</Citation></Reference><Reference><Citation>Liao Y, Yin B, Jin Z, Bao G, Li Y. TCM theoretical analysis and modern pharmacological mechanism of huashi baidu decoction in treating severe novel coronavirus Pneumonia. J Hainan Med Univ. (2020) 26:1209&#x2013;13.</Citation></Reference><Reference><Citation>Sun Y, Lu W, Li H, Xiao Y, Yang M, Yang H, et al. Qingfei Paidu Decoction for Treatment of Mild/ Moderate COVID-19 in 295 cases: a multi-centered. J Trad Chin Med. (2021) 62:599&#x2013;603.</Citation></Reference><Reference><Citation>Wang Y, Li X, Zhang J, Xue R, Qian J, Zhang X, et al. Mechanism of Xuanfei Baidu Tang in Treatment of Covid-19 Based on Network Pharmacology. Chin J Chin Mater Med. (2020) 45:2249&#x2013;56. 10.19540/j.cnki.cjcmm.20200325.401</Citation><ArticleIdList><ArticleId IdType="doi">10.19540/j.cnki.cjcmm.20200325.401</ArticleId><ArticleId IdType="pubmed">32495577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Zhang B, Li K, Lu J, Hu XA. Rapid health technology assessment of Xuebijing Injection. Chin J Ration Drug Use. (2020) 17:6&#x2013;14.</Citation></Reference><Reference><Citation>Peng W, Su J, Xu Q, Wang Q, Jiang X. Meta-analysis of clinical efficacy of traditional Chinese Medicine intervention in chronic fatigue syndrome. Guangm J Chin Med. (2013) 28:1345&#x2013;9.</Citation></Reference><Reference><Citation>Liu M, Chen M, Wei C, Zhao Q. Treatment of idiopathic pulmonary fibrosis by traditional Chinese medicine: a systematic review and meta-analysis. Tianjin J Trad Chin Med. (2018) 35:200&#x2013;4.</Citation></Reference><Reference><Citation>Li J, Yang W. Meta-analysis of clinical efficacy of integrated traditional Chinese and Western Medicine in the Treatment of Insomnia. Chin J Integr Med Cardio-Cerebrovasc Dis. (2012) 10:40&#x2013;2.</Citation></Reference><Reference><Citation>Feng Q, Cui H, Yu H, Zhang Y. Expert guiding opinions on comprehensive Chinese Medicine Intervention Plan for Novel Coronavirus Pneumonia Convalescence (Draft). Beijing J Trad Chin Med. (2020) 39:102&#x2013;4.</Citation></Reference><Reference><Citation>General Office of National Health Commission of the People&#x2019;s Republic of China, Office of National Administration of Traditional Chinese Medicine. Diagnosis and treatment of corona virus disease-19 (8th Trial Edition). Chin Med. (2020) 15:1494&#x2013;9.</Citation></Reference><Reference><Citation>Wang C, Wu S, Jiang L, Xu W, Yang Y, Hu J. Comprehensive analysis of tcm diagnosis and treatment schemes for Covid-19 in all regions of China. Modern Tradit Chin Med Mater Medica-World Sci Technol. (2020) 22:257&#x2013;63.</Citation></Reference><Reference><Citation>Zhong L, Wong Y, Leung C, Peng B, Lin Z, Wong Taam V, et al. Effects of Chinese Medicine for Covid-19 rehabilitation: a multicenter observational study. Chin Med. (2022) 17:99. 10.1186/s13020-022-00654-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-022-00654-z</ArticleId><ArticleId IdType="pmc">PMC9395813</ArticleId><ArticleId IdType="pubmed">35996191</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang W, Yang F, Zhao Y, Dai E, Feng J, Huang Y, et al. Qingjin Yiqi Granules for Post-Covid-19 condition: a randomized clinical trial. J Evid Based Med (2022) 15:30&#x2013;8. 10.1111/jebm.12465</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jebm.12465</ArticleId><ArticleId IdType="pmc">PMC9114922</ArticleId><ArticleId IdType="pubmed">35416437</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M, Vink-Niese A. Could cognitive behavioural therapy be an effective treatment for long covid and post COVID-19 fatigue syndrome? Lessons from the qure study for Q-fever fatigue syndrome. Healthcare. (2020) 8:552. 10.3390/healthcare8040552</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8040552</ArticleId><ArticleId IdType="pmc">PMC7764131</ArticleId><ArticleId IdType="pubmed">33322316</ArticleId></ArticleIdList></Reference><Reference><Citation>Exarchos K, Sioutkou A, Chronis C, Peristeri S, Gogali A, Konstantinidis A, et al. Validation study of the portable air next spirometer: preliminary results. Eur Respir J. (2019) 54(Suppl. 63):A2642. 10.1183/13993003.congress-2019.PA2642</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.congress-2019.PA2642</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L. Clinical observation of xiangsha liujunzi decoction combined with Western medicine in the treatment of chronic atrophic gastritis. Guangm J Chin Med. (2019) 34:2834&#x2013;6.</Citation></Reference><Reference><Citation>Zhang Q. Effectiveness observation of shashen maidong decoction of TCM in acute tracheobronchitis. Chin J Ethnomed Ethnopharm. (2018) 27:88&#x2013;101.</Citation></Reference><Reference><Citation>Chen B. Observation on the efficacy and safety of self-made zaoren fushen decoction combined with Western Medicine in the Treatment of Insomnia. Women&#x2019;s Health Res. (2016) 11:39&#x2013;40.</Citation></Reference><Reference><Citation>Yu T. Clinical Study of Differently Prepared Cheqianzi in the Treatment of Chronic Functional Constipation. Henan Trad Chin Med. (2015) 35:1064&#x2013;5.</Citation></Reference><Reference><Citation>Zhou Q. Clinical Research of Modified Shuganhewei Drinks Treating Functional Dyspepsia (Liver-Stomach Heat Syndrome). Master&#x2019;s thesis. Nanjing: Nanjing University of Chinese Medicine; (2016).</Citation></Reference><Reference><Citation>Li D, Ye P, Tian S, Jiang M, Xu Y, Hou L, et al. Clinical observation of zhebei and its formula granules in the treatment of refractory acute leukemia. Chin Arch Trad Chin Med. (2006) 8:1449&#x2013;50.</Citation></Reference><Reference><Citation>Xiong H. Advances in clinical application of astragalus membranaceus and drug adverse Reaction. Pharm Care Res. (2002) 3:180&#x2013;2.</Citation></Reference><Reference><Citation>He C, Zhao Y, Zhou L, Gao Q, Ge C. 3. Cases of adverse reactions caused by gualoupi injection. Chin J Hosp Pharmacy. (2017) 37:316&#x2013;7.</Citation></Reference><Reference><Citation>Keijmel S, Delsing C, Bleijenberg G, van der Meer J, Donders R, Leclercq M, et al. Effectiveness of long-term doxycycline treatment and cognitive-behavioral therapy on fatigue severity in patients with q fever fatigue syndrome (Qure Study): a randomized controlled trial. Clin Infect Dis (2017) 64:998&#x2013;1005. 10.1093/cid/cix013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix013</ArticleId><ArticleId IdType="pubmed">28329131</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin &#xc5;, Taft C, Lundgren-Nilsson &#xc5;, Dencker A. Minimal important differences for fatigue patient reported outcome measures-a systematic review. BMC Med Res Methodol. (2016) 16:62. 10.1186/s12874-016-0167-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-016-0167-6</ArticleId><ArticleId IdType="pmc">PMC4937582</ArticleId><ArticleId IdType="pubmed">27387456</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Fang Z, Ong K, Ye D, Wang W, Chen Y, et al. Clinical observation of the rehabilitation formula for banking up earth to generate metal in treating Covid-19 patients with deficiency of lung and spleen syndrome in the recovery stage. J Nanjing Univ Trad Chin Med. (2020) 36:281&#x2013;5.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>